Dr. Peter Marks, the director of the FDA’s Center for Biologics Evaluation and Research, has revealed his plan to space out his vaccinations for COVID-19, flu, and respiratory syncytial virus (RSV) over the coming weeks. This decision is based on the belief that spacing out vaccines can help minimize any potential side effects.
While the Centers for Disease Control and Prevention (CDC) allows for coadministration or simultaneous administration of vaccines, like getting the COVID-19 and flu shots at the same time, Marks believes that spreading the vaccinations apart can provide better protection and reduce the likelihood of experiencing adverse reactions.
Dr. Marks will begin with an updated COVID-19 vaccine, as it appears to be effective against the current strains of the virus. Not only will this vaccine offer protection against the existing variants, but it is also expected to safeguard against closely-related descendants and the BA.2.86 variant.
Looking ahead, Marks anticipates that health authorities may recommend an additional COVID-19 vaccine dose for vulnerable groups later in the year. This is in line with the ongoing efforts to provide optimum protection, especially for those at higher risk.
In terms of flu vaccination, Dr. Marks plans to receive his shot in early October. This timing is strategic, as the effectiveness of flu vaccines tends to weaken over time, and getting the shot before the peak flu season, which typically occurs between December and February, can help maximize protection.
Additionally, this year brings new options for RSV vaccination, particularly for older adults and pregnant individuals. RSV infections have been rapidly spreading in certain parts of the country, especially in the Southeast. To help combat this, Pfizer has developed a new RSV vaccine recommended for pregnant individuals between weeks 32 and 36 of pregnancy. This vaccine not only protects expectant mothers but also helps safeguard newborns from contracting RSV.
Dr. Peter Marks’ decision to space out his COVID-19, flu, and RSV vaccinations highlights the importance of individualized healthcare decision-making. By getting updated vaccines and spacing out their administration, individuals can better protect themselves against these infectious diseases while minimizing any potential side effects. Stay up-to-date with the recommendations from health authorities, as further doses or boosters may be required for certain populations in the future.
